Monica Miozzo is a leading figure in human genetics, specializing in epigenetic modifications, imprinting disorders, and molecular profiling of rare diseases and cancer.
She directs the ASST Santi Paolo e Carlo Medical Genetics Unit in Milan, oversees training for genetic specialists, and contributes to shaping national recommendations for precision medicine (germline pharmacogenetics).
Education & Credentials
- Laurea (MSc) in Biological Sciences – University of Milan (1987)
- Specialist Degree in Medical Genetics – University of Milan (1995)
- Ph.D. in Cellular & Molecular Biology – University of Milan (1999)
Professional Experience & Contributions
- Director of the complex unit of Medical Genetics, ASST Santi Paolo e Carlo, Milan
- Full Professor, Medical Genetics (MED/3), University of Milan
- Director, School of Specialization in Medical Genetics, University of Milan
- Coordinator of one of the Next-Generation Sequencing (NGS) Facilities within the Lombardy Regional Network.
- Serves as a Spoke Leader within a PNRR-PNC project (D3 4Health) and Coordinator of a research unit in a national project (Tornado) supported by the Italian Ministry of Defence.
Areas of Expertise
- Molecular diagnosis of rare diseases and somatic profiling in tumors
- Epigenetic modifications in hereditary and complex diseases
- Genetic testing in national health services
Awards & Honors
- Award: “Premio Isimbardi Provincia di Milano” for scientific career (2009)
Leadership & Affiliations
- Member of the Società Italiana di genetica Umana (SIGU) and of the European Society of Human Genetics (ESHG).
- Coordinator of the Pharmacogenetics Working Group (2023–2025), Italian Society of Human Genetics (SIGU).
- Reviewer and evaluator for national and international research funding bodies (EU FP6, FP7, national agencies).
Publications & Media
H-index 47 (Scopus); 53 (Google Scholar); ~150+ indexed publications; >8,000 citations (Scopus)
